19th Conference of the International Society of Geriatric Oncology
R

Radiation Therapy in HER+ Breast Cancer: Relative Benefits Are Constant and Relate to Biology and Absolute Benefits Are Often Small

By 19th Conference of the International Society of Geriatric Oncology FEATURING Richard Simcock
By 19th Conference of the International Society of Geriatric Oncology FEATURING Richard Simcock
16 views
December 27, 2019
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
14:16
Dana-Farber Cancer Institute

Year in Review: Breast Cancer

Feat. P. Tarantino
17:20
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Top 5 Breast Cancer Studies Including KEYNO…

Feat. P. Tarantino
57:44
Vogl, NY

Vogl,NY on How to Ask Good Questions at Medical Meetings

Feat. S. Vogl
49:07
SABCS 2022 Conference Coverage

SABCS 2022 Expert Panel Discussion: Practice-Changing Updates

Feat. J. O'Shaughnessy, S. Tolaney, S. Hurvitz, H. Rugo
17:35
Insights from 2023 SABCS

SABCS 2023 Summary: "Top 5 Studies Including KATHERINE & HE…

Feat. P. Tarantino
30:46
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Panel Discussion: "Metastatic Breast Cancer"

Feat. S. Tolaney, H. Rugo
13:23
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…

Feat. S. Hurvitz
05:45
SABCS 2022 Conference Coverage

SABCS 2022 Adjuvant Paclitaxel & Trastuzumab for Node- HER2+ BC:…

Feat. S. Tolaney
11:19
Adam Brufsky

HER2+ mBC: The Role of TDM-1

07:34
PrecisCa

Summary of the Updated Results of SOFT/TEXT Trials and the Meta-Anal…

Feat. M. Pegram
07:49
UChicago Medicine

Antibody Drug Conjugates: Overview and Background of a Revolution in…

Feat. H. Rugo
22:49
Oncology Data Advisor

Highlights of the 2023 SABCS: HER2CLIMB-02, MONARCH3, and INAVO120 T…

Feat. J. Mouabbi
19:34
Keck School of Medicine of USC

Breast Cancer Oligometastases and Beyond

Feat. S. Chmura
26:30
Insights from 2023 SABCS

SABCS 2023 Summary: "HER2+ BC Highlights From KATHERINE & H…

Feat. S. Tolaney, H. Rugo
11:10
Dana-Farber Cancer Institute

Antibody Drug Conjugates in Breast Cancer

Feat. S. Tolaney
10:54
Yale Cancer Center

De-Escalation of Adjuvant Therapy in Early Stage HER2+ Breast Cancers

Feat. L. Pusztai
26:28
2023 West Oncology Conference

Antibody Drug Conjugates for Breast Cancer: The End of Chemotherapy?

Feat. L. Schwartzberg
12:13
UChicago Medicine

Trastuzumab Deruxtecan in HER2+ mBC

Feat. H. Rugo
08:41
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III…

Feat. P. Conte
21:44
Yale Cancer Center

Updates on Metastatic Breast Cancer - Yale Cancer Center

Feat. D. O'Neil